Recent news on Nevanac

The Cost of Clinical Trials  -  Mar 20, 2007
Drug Discovery & Development,Johns Hopkins University announces plans to study the effects of several ocular drugs (Bromfenac, also called Xibrom; Nepafenac, also called Nevanac;

Pharma Sector: Few Newsmakers Of The Week - Opexa, J&J, Glaxo ...  -  Feb 11, 2007
Trading Markets,Alcon's Nevanac, Novartis' Voltaren, Allergan's Acular are the other star players which belong to the class of nonsteroidal anti-inflammatory drugs for

Alcon's Fourth Quarter Sales Rise 16.1 Percent  -  Feb 8, 2007
PharmaLive.com (press release),...products rose 22.2 percent to $183.3 million, mainly due to US share gains for Vigamox(R) ophthalmic solution and Nevanac(R) ophthalmic suspension.

Alcon Q4 Profit Jumps; Sees Higher FY07 Profit  -  Feb 7, 2007
Trading Markets,...anti-inflammation products rose 22.2% to $183.3 million, mainly due to US share gains for Vigamox ophthalmic solution and Nevanac ophthalmic suspension.

An eye for innovation  -  Dec 14, 2006
OCRegister,Ista's Xibrom twice-a-day drops for pain relief after cataract surgery are gaining market share against Alcon's three-times-a-day Nevanac, he says.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional